Pharmaceuticals (12) | Distribution Agreements (12)

Browse by Company

Recent Contracts

Licensing and Distribution Agreement between Sonoma Pharmaceuticals, Inc. and Gabriel Science, LLC, effective December 14, 2020 (Sonoma Pharmaceuticals, Inc., Filed With SEC on December 17, 2020)
Exclusive Licensing and Distribution Agreement between Sonoma Pharmaceuticals, Inc. and Crown Laboratories, Inc., effective December 4, 2020 (Sonoma Pharmaceuticals, Inc., Filed With SEC on December 10, 2020)
First Amendment to Exclusive Distribution Agreement (Revance Therapeutics, Inc., Filed With SEC on November 9, 2020)
Distribution Agreement between the Registrant and Biomet 3i LLC d/b/a Zimmer Biomet Dental, dated July 17, 2020 (ACELRX PHARMACEUTICALS INC, Filed With SEC on November 5, 2020)
Distribution and Commercialization Agreement between the Company and USWM, LLC (Adamis Pharmaceuticals Corp, Filed With SEC on August 17, 2020)
First Amendment to Intermediary Distribution Agreement between the Company and Chongqing Pioneer Pharma Holdings Limited, dated June 29, 2020 (NovaBay Pharmaceuticals, Inc., Filed With SEC on August 6, 2020)
Pharmacy Master Services Agreement, dated as of July 1, 2020, by and between Jazz Pharmaceuticals, Inc. and Express Scripts Specialty Distribution Services, Inc (Jazz Pharmaceuticals plc, Filed With SEC on August 4, 2020)
International Distribution Agreement, dated April 16, 2020 (NovaBay Pharmaceuticals, Inc., Filed With SEC on April 20, 2020)
Intermediary Distribution Agreement, dated April 16, 2020 (NovaBay Pharmaceuticals, Inc., Filed With SEC on April 20, 2020)
Form of Distribution Agreement dated February 26, 2020 by and among cbdMD, Inc., CBD Holdings, LLC and the members of CBD Holdings, LLC (Level Brands, Inc., Filed With SEC on February 28, 2020)